Idarubicin and IR780 co-loaded PEG-b-PTMC nanoparticle for non-Hodgkin’s lymphoma therapy by photothermal/photodynamic strategy

Idarubicin and IR780 co-loaded PEG-b-PTMC nanoparticle for non-Hodgkin’s lymphoma therapy by photothermal/photodynamic strategy

A certain proportion of non-Hodgkin’s lymphoma (NHL) patients will relapse after standard chemotherapy with an anthracycline-based regimen. Therefore, identifying novel therapeutic methods are a vital topic for improving therapeutic effects of NHL. IR780, a near-infrared dye, can be used as a photos...

Full description

Bibliographic Details
Main Authors: Shanshan Weng, Luqi Pan, Dawei Jiang, Wenxia Xie, Zhiyuan Zhang, Changcan Shi, Bin Liang, Shenghao Wu
Format: Article
Language:English
Published: Elsevier 2023-06-01
Series:Materials & Design
Subjects:
Non-Hodgkin’s lymphoma
IR780
Paclitaxel
Combination therapy
Nanoparticle
Online Access:http://www.sciencedirect.com/science/article/pii/S0264127523004239

Internet

http://www.sciencedirect.com/science/article/pii/S0264127523004239

Similar Items